Public list Pharma Startups (6570):
CytoSolv Inc., is a new company that is developing a drug to help heal wounds. The company is developing the drug from the brain cells of pigs.
Company (Alive / Active)
Rhode Island, United States
|Investor||Investor Type||Location||Participating Rounds|
|Madison, Wisconsin, United States||Alive / Active||NeuroGenomeX is a drug discovery company developing novel treatments for diseases of the brain and nervous system. The current NeuroGenomeX discovery program is focused on therapeutic target areas of epilepsy and traumatic brain injury. NeuroGenomeX is advancing its lead drug candidate, 2-deoxy-D-glucose (2DG), as an anticonvulsant that stops seizures and has beneficial effects against adverse long-term consequences of epilepsy. 2DG also has shown favorable therapeutic neuroprotective effects in...Show all||Login to see details|
|Parsippany, New Jersey, United States||IPO / Went public||The Medicines Company's purpose is to save lives, alleviate suffering and contribute to the economics of healthcare by focusing on 3,000 leading acute/intensive care hospitals worldwide. The company's vision is to be a leading provider of solutions in three areas: acute cardiovascular care, surgery and perioperative care, and serious infectious disease care.||Login to see details|